FIELD: medicine, purulent surgery.
SUBSTANCE: it is necessary to apply dressings with suspension consisting of thrombocytes-rich plasma, 10%-CaCl2 solution at equal volume and antibacterial preparation to which ulcerous microflora is sensitive. The volume of dressing for 1 dressing should be determined by the following formula: V=S×h×C, where S - the area of ulcerous defect, h - its depth, C - the coefficient. At the rate of ulcerous surface epithelization being under 25% weekly C=1.25, and at the rate being above 25% weekly C=1.0. The innovation provides the chance for individual dosing autogenous tissue growth factors and matched efficient antibacterial preparations and, thus, accelerated phase II of wound process and shortened terms of epithelization of ulcerous defects in the present category of patients.
EFFECT: higher efficiency of therapy.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR AMPUTATING TOES AT PURULENT-NECROTIC COMPLICATIONS OF DIABETIC FOOT SYNDROME | 2005 |
|
RU2284781C1 |
METHOD FOR SURGICAL TREATMENT OF FOOT PHLEGMONS IN CASE OF DIABETES MELLITUS | 2016 |
|
RU2643674C1 |
METHOD FOR SURGICAL TACTICS SELECTION DURING DIABETIC FOOT TREATMENT | 2016 |
|
RU2621945C1 |
METHOD FOR ASSESSMENT OF CLINICAL COURSE OF WOUND PROCESS IN PATIENTS WITH DIABETIC FOOT SYNDROME | 2018 |
|
RU2696565C1 |
TREATMENT METHOD OF PURULENT-NECROTIC WOUNDS | 2019 |
|
RU2727867C1 |
PERSISTENT WOUND HEALING APPROACH IN PATIENTS SUFFERING FROM PANCREATIC DIABETES | 2008 |
|
RU2358757C1 |
METHOD TO TREAT ULCEROUS DEFECTS AT DIABETIC FOOT SYNDROME | 2000 |
|
RU2178310C1 |
METHOD OF TREATING DEFECTS OF SKIN AND SOFT TISSUES IN PATIENTS WITH DIABETES MELLITUS AND METHOD OF INTRODUCTION OF DRUG THEREFOR | 2017 |
|
RU2679449C1 |
METHOD OF TREATING TROPHIC ULCERS IN DIABETIC FOOT SYNDROME | 2018 |
|
RU2695706C1 |
METHOD FOR REGIONAL TREATMENT OF TROPHIC ULCERS | 2016 |
|
RU2657806C2 |
Authors
Dates
2008-04-20—Published
2006-06-16—Filed